Atraverse Medical

Developing the next generation toolset for transseptal crossing -- a necessary procedural step for a myriad of cardiac interventions.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Chicago, IL, USA
  • Currency USD
  • Founded July 2022
  • Employees 10
  • Incorporation Type C-corp
  • Website atraversemedical.com

Company Summary

Atraverse is a medical device company dedicated to developing a next-generation toolset for the $1B+ left-heart access market – a broad category of minimally invasive interventions including over 1M annual electrophysiology and structural heart patient procedures. The company’s first product is an innovative transseptal crossing system designed to improve patient outcomes, lower the cost of care, and address clinical workflow inefficiencies.

Team

  • COO & Co-Founder

    10+ years medtech development and marketing experience in EP / cardiac therapy space. Prior Sr. Product Manager at Acutus Medical. Prior engineer at Farapulse (Employee #1), Abbott, Teleflex, Access Point Technologies, Freudenberg.

  • President/CEO & Co-Founder

    Serial medtech entrepreneur and operator who has sourced over $200M of startup capital and has over $1B of exits across three deals in the medical device industry Co-Founder Farapulse acquired for $800M+ by Boston Scientific (NYSE: BSX). Co-Founder/CFO of Attune Medical acquired by Haemonetics (NYSE: HAE) for $160M up-front plus uncapped 3-year revenue earnout. Prior CFO at SIA acquired for up to $140M by Integra LifeSciences (NASDAQ: IART).

  • Chief Translational Science Officer & Co-Founder

    Practicing cardiac electrophysiology physician at Scripps (San Diego, CA) and serial medtech entrepreneur. Prior executive at Acutus (NYSE: AFIB). Co-Founder and Inventor of Farapulse acquired for $800M+ by Boston Sci (NYSE: BSX).

  • SVP Quality & Regulatory Affairs

    Charles brings over 20 years of medical device regulatory and quality experience, has secured cardiovascular device approvals in U.S., Europe, and Japan and has successfully supported FDA and other regulatory body audits. Previously, Charles worked with Blockade Medical (acquired by Balt in 2016), Ablation Frontiers (acquired by Medtronic for up to $225M), and Edwards Lifesciences. Charles received a B.S. in Bioengineering at UCSD.

  • Chief Marketing Officer

    20 years of medical device experience primarily in cardiac EP. Prior leadership roles at Medtronic and J&J plus experience as an early employee at several start-ups, including Ablation Frontiers, acquired in 2009 by Medtronic for $225M, and Filmetrics, acquired by KLA in 2019. Jay holds a Bioengineering degree from UCSD, a Master's in Biomedical Engineering from the Keck Graduate Institute, and an MBA from the Drucker School of Management.

  • Brandon Allen
    VP Sales

    Brandon is a distinguished leader with +20 years of experience in the medical device industry selling to cardiac EP's. Most recently, he was the VP Sales at Acutus Medical where he crafted the commercial strategy for the IPO and achieved eight consecutive quarters of growth on revenue and procedural volume. Mr. Allen holds a B.S. from Louisiana Tech University.

Advisors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free